Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Pharmacology|June 6, 2018
Proton Pump Inhibitors in IPF: A Call for Clinical TrialsYohannes T GhebreAmerican Journal of Respiratory and Critical Care Medicine|April 26, 2016
Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic DrugsYohannes T Ghebre, Ganesh RaghuThe American Journal of Case Reports|May 31, 2018
Silent Neoplastic Cardiac Invasion in Small Cell Lung Cancer: A Case Report and Review of the LiteratureNgoc Pham, Mark D Bonnen, Yohannes T GhebreFrontiers in Oncology|August 22, 2022
Proton pump inhibitors and sensitization of cancer cells to radiation therapyKassidy A Hebert, Mark D Bonnen, Yohannes T GhebreFrontiers in Oncology|June 5, 2023
Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovationShraddha M Dalwadi, Andrew Hunt, Mark D Bonnen, et al.Cell Reports|April 28, 2016
Optimal ROS Signaling Is Critical for Nuclear ReprogrammingGang Zhou, Shu Meng, Yanhui Li, et al.Journal of Cellular Physiology|January 20, 2022
Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblastsShubham Dubey, Praveen K Dubey, Channakeshava S Umeshappa, et al.Chest|April 19, 2019
Radiation-Induced Lung Injury: Assessment and ManagementAlexander N Hanania, Walker Mainwaring, Yohannes T Ghebre, et al.The Journal of Pharmacology and Experimental Therapeutics|November 18, 2018
Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic ProcessesAfshin Ebrahimpour, Samana Shrestha, Mark D Bonnen, et al.Circulation Research|May 12, 2016
Proton Pump Inhibitors Accelerate Endothelial SenescenceGautham Yepuri, Roman Sukhovershin, Timo Z Nazari-Shafti, et al.Pageof 3